1
|
Saika K and Sobue T: Cancer statistics in
the world. Gan To Kagaku Ryoho. 40:2475–2480. 2013.(In Japanese).
PubMed/NCBI
|
2
|
Malvezzi M, Bertuccio P, Levi F, La
Vecchia C and Negri E: European cancer mortality predictions for
the year 2013. Ann Oncol. 24:792–800. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yang G, Wang Y, Zeng Y, et al: Rapid
health transition in China, 1990–2010: findings from the Global
Burden of Disease Study 2010. Lancet. 381:1987–2015. 2013.
View Article : Google Scholar : PubMed/NCBI
|
4
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Son JW: Year-in-Review of Lung Cancer.
Tuberculosis and respiratory diseases. 73:137–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Agullo-Ortuno MT, Lopez-Rios F and
Paz-Ares L: Lung cancer genomic signatures. J Thorac Oncol.
5:1673–1691. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wilson BG and Roberts CW: SWI/SNF
nucleosome remodellers and cancer. Nat Rev Cancer. 11:481–492.
2011. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Oike T, Ogiwara H, Nakano T, Yokota J and
Kohno T: Inactivating mutations in SWI/SNF chromatin remodeling
genes in human cancer. Jpn J Clin Oncol. 43:849–855. 2013.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Reisman D, Glaros S and Thompson EA: The
SWI/SNF complex and cancer. Oncogene. 28:1653–1668. 2009.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Manceau G, Letouze E, Guichard C, et al:
Recurrent inactivating mutations of ARID2 in non-small cell lung
carcinoma. Int J Cancer. 132:2217–2221. 2013. View Article : Google Scholar
|
11
|
Jones S, Li M, Parsons DW, et al: Somatic
mutations in the chromatin remodeling gene ARID1A occur in several
tumor types. Human Mutat. 33:100–103. 2012. View Article : Google Scholar
|
12
|
Rodriguez-Nieto S, Cañada A, Pros E, et
al: Massive parallel DNA pyrosequencing analysis of the tumor
suppressor BRG1/SMARCA4 in lung primary tumors. Hum Mutat.
32:E1999–E2017. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ho L, Ronan JL, Wu J, et al: An embryonic
stem cell chromatin remodeling complex, esBAF, is essential for
embryonic stem cell self-renewal and pluripotency. Proc Natl Acad
Sci USA. 106:5181–5186. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kadoch C, Hargreaves DC, Hodges C, et al:
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes
identifies extensive roles in human malignancy. Nat Genet.
45:592–601. 2013. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Forbes SA, Bindal N, Bamford S, et al:
COSMIC: mining complete cancer genomes in the Catalogue of Somatic
Mutations in Cancer. Nucleic Acids Res. 39:D945–D950. 2011.
View Article : Google Scholar :
|
16
|
Bamford S, Dawson E, Forbes S, et al: The
COSMIC (Catalogue of Somatic Mutations in Cancer) database and
website. Br J Cancer. 91:355–358. 2004.PubMed/NCBI
|
17
|
Koziol JA: A note on efficient estimation
of mutation rates using Luria-Delbrück fluctuation analysis. Mutat
Res. 249:275–280. 1991. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hall BM, Ma CX, Liang P and Singh KK:
Fluctuation analysis calculator: a web tool for the determination
of mutation rate using Luria-Delbruck fluctuation analysis.
Bioinformatics. 25:1564–1565. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wistuba II, Gazdar AF and Minna JD:
Molecular genetics of small cell lung carcinoma. Semin Oncol.
28:3–13. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
Takahashi T, Suzuki H, Hida T, Sekido Y,
Ariyoshi Y and Ueda R: The p53 gene is very frequently mutated in
small-cell lung cancer with a distinct nucleotide substitution
pattern. Oncogene. 6:1775–1778. 1991.PubMed/NCBI
|
21
|
Dearden S, Stevens J, Wu YL and Blowers D:
Mutation incidence and coincidence in non small-cell lung cancer:
meta-analyses by ethnicity and histology (mutMap). Ann Oncol.
24:2371–2376. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Liu X, Lin XJ, Wang CP, et al: Association
between smoking and p53 mutation in lung cancer: a meta-analysis.
Clin Oncol (R Coll Radiol). 26:18–24. 2014. View Article : Google Scholar
|
23
|
de la Serna IL, Carlson KA and Imbalzano
AN: Mammalian SWI/SNF complexes promote MyoD-mediated muscle
differentiation. Nat Genet. 27:187–190. 2001. View Article : Google Scholar : PubMed/NCBI
|
24
|
Watanabe H, Mizutani T, Haraguchi T, et
al: SWI/SNF complex is essential for NRSF-mediated suppression of
neuronal genes in human nonsmall cell lung carcinoma cell lines.
Oncogene. 25:470–479. 2006.
|
25
|
Vradii D, Wagner S, Doan DN, et al: Brg1,
the ATPase subunit of the SWI/SNF chromatin remodeling complex, is
required for myeloid differentiation to granulocytes. J Cell
Physiol. 206:112–118. 2006. View Article : Google Scholar
|
26
|
Romero OA and Sanchez-Cespedes M: The
SWI/SNF genetic blockade: effects in cell differentiation, cancer
and developmental diseases. Oncogene. 33:2681–2689. 2014.
View Article : Google Scholar
|
27
|
Euskirchen GM, Auerbach RK, Davidov E, et
al: Diverse roles and interactions of the SWI/SNF chromatin
remodeling complex revealed using global approaches. PLoS Genet.
7:e10020082011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kasten MM, Clapier CR and Cairns BR:
SnapShot: chromatin remodeling: SWI/SNF. Cell. 144:310.e12011.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Xu Y and Price BD: Chromatin dynamics and
the repair of DNA double strand breaks. Cell Cycle. 10:261–267.
2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Matsubara D, Kishaba Y, Ishikawa S, et al:
Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal
transition phenotype and distinct histologic and genetic features.
Cancer Sci. 104:266–273. 2013. View Article : Google Scholar
|
31
|
Cohen SM, Chastain PD II, Rosson GB, et
al: BRG1 co-localizes with DNA replication factors and is required
for efficient replication fork progression. Nucleic Acids Res.
38:6906–6919. 2010. View Article : Google Scholar : PubMed/NCBI
|